Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.

Impact, resistance training cuts risk of osteoporosis fractures in Crohn’s disease

23 Aug 2020

Patients with Crohn’s disease (CD) risk developing osteoporosis and related fractures, but this may be countered by performing combined impact and resistance training exercises, which confer benefits for bone mineral density (BMD) and muscle function, a study has shown.

Forty-seven adults with stable CD (mean age, 49.3 years; 68 percent female) were assigned to undergo an exercise intervention (n=23) or receive usual care alone (n=24; control) for 6 months. The exercise group received usual care plus a combined impact and resistance training programme. Patients underwent three 60‐minute sessions per week, with a gradual tapering of supervision to self‐management.

None of the patients smoked, and most had quiescent disease (66 percent). The median time since CD diagnosis was 216 months. According to baseline BMD measurements (measured using dual energy X‐ray absorptiometry), 12 patients (25 percent) had evidence of osteopaenia or osteoporosis at the lumbar spine and 20 (43 percent) at the left hip. The most common medications used for CD were immunosuppressants (43 percent) and biologics (40 percent); none were on corticosteroids.

At 6 months, BMD values were better in the exercise vs the control group, with the difference significant at lumbar spine (adjusted mean difference [MD], 0.036 g/cm2, 95 percent confidence interval [CI] 0.024–0.048; p<0.001), but not at femoral neck (adjusted MD, 0.018 g/cm2, 95 percent CI, 0.001–0.035; p=0.059) nor at greater trochanter (adjusted MD, 0.013 g/cm2, 95 percent CI, −0.019 to 0.045; p=0.415).

Furthermore, the exercise intervention yielded improvements in all muscle function outcomes (unadjusted MDs ranging 22.6‒48.2 percent; p<0.001) and fatigue severity (p=0.005).

There were three exercise‐related adverse events: two instances of light‐headedness and one of nausea.

The findings highlight the intervention as a suitable model of exercise for reducing the future risk of osteoporotic fractures and physical disability in this high‐risk population, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.

Pearl Toh, 6 days ago
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Elvira Manzano, 17 Nov 2020
Invasive fungal infections, particularly those caused by Candida species, are common in hospitalized, immunocompromised, or critically ill patients and are associated with considerable morbidity and mortality.